1. Bioorg Med Chem Lett. 2007 Feb 1;17(3):657-61. doi:
10.1016/j.bmcl.2006.10.096.  Epub 2006 Nov 6.

Novel pyrazolopiperazinone- and pyrrolopiperazinone-based MCH-R1 antagonists.

Meyers KM(1), MÃ©ndez-Andino J, Colson AO, Hu XE, Wos JA, Mitchell MC, Hodge K, 
Howard J, Paris JL, Dowty ME, Obringer CM, Reizes O.

Author information:
(1)Procter and Gamble Pharmaceuticals, 8700 Mason-Montgomery Road, Mason, OH 
45039, USA.

The synthesis and biological testing of novel classes of potent 
melanin-concentrating hormone (MCH-R1) antagonists based on pyrazolopiperazinone 
and pyrrolopiperazinone scaffolds are described.

DOI: 10.1016/j.bmcl.2006.10.096
PMID: 17174091 [Indexed for MEDLINE]
